Dirk Scharn
11Patents
3h-index
39Co-inventors
56Inventor score
Filing activity: Jul 19, 2004 → Oct 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8071810B2 | C5a receptor antagonists | Chemistry; Metallurgy | 10 | Active |
| US7727960B2 | C5a receptor antagonists | Chemistry; Metallurgy | 4 | Expired |
| US8029979B2 | Method for determining the substrate specificity of an enzyme | Chemistry; Metallurgy | 4 | Active |
| US8309735B2 | Heterocyclic compounds for the inhibition of integrins and use thereof | Chemistry; Metallurgy | 2 | Active |
| US8927534B2 | Compounds for the inhibition of integrins and use thereof | Chemistry; Metallurgy | 2 | Active |
| US8410134B2 | 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US11174245B2 | Benzimidazole compounds and derivatives as EGFR inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11261184B2 | [1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors | Human Necessities | 0 | Active |
| US12064421B2 | Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors | Human Necessities | 0 | Active |
| US11213520B2 | Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11608343B2 | Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.